Kaira K - Search Results

1

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.

Yamaguchi O, Imai H, Minemura H, Suzuki K, Wasamoto S, Umeda Y, Osaki T, Kasahara N, Uchino J, Sugiyama T, Ishihara S, Ishii H, Naruse I, Mori K, Kotake M, Kanazawa K, Minato K, Kagamu H, Kaira K. Yamaguchi O, et al. Among authors: kaira k. Cancer Chemother Pharmacol. 2020 Apr;85(4):761-771. doi: 10.1007/s00280-020-04055-7. Epub 2020 Mar 19. Cancer Chemother Pharmacol. 2020. PMID: 32193618

2

Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer.

Kaira K, Takise A, Kobayashi G, Utsugi M, Horie T, Mori T, Imai H, Inazawa M, Mori M. Kaira K, et al. Jpn J Clin Oncol. 2005 Feb;35(2):57-60. doi: 10.1093/jjco/hyi019. Jpn J Clin Oncol. 2005. PMID: 15709087

3

Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer.

Kaira K, Takise A, Minato K, Iwasaki Y, Ishihara S, Takei Y, Tsuchiya S, Saito R, Sato K, Mori M. Kaira K, et al. Anticancer Drugs. 2005 Apr;16(4):455-60. doi: 10.1097/00001813-200504000-00013. Anticancer Drugs. 2005. PMID: 15746583 Clinical Trial.

4

[Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy].

Kaira K, Watanabe R, Takise A, Endou K, Kamiyoshihara M, Mori M. Kaira K, et al. Gan To Kagaku Ryoho. 2005 Nov;32(12):1989-92. Gan To Kagaku Ryoho. 2005. PMID: 16282742 Japanese.

5

Fulminant hepatic failure resulting from small-cell lung cancer and dramatic response of chemotherapy.

Kaira K, Takise A, Watanabe R, Mori M. Kaira K, et al. World J Gastroenterol. 2006 Apr 21;12(15):2466-8. doi: 10.3748/wjg.v12.i15.2466. World J Gastroenterol. 2006. PMID: 16688847 Free PMC article.

6

A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer.

Kaira K, Tsuchiya S, Sunaga N, Yanagitani N, Watanabe S, Imai H, Hisada T, Ishizuka T, Saito R, Mori M. Kaira K, et al. Am J Clin Oncol. 2007 Feb;30(1):51-6. doi: 10.1097/01.coc.0000242292.17728.46. Am J Clin Oncol. 2007. PMID: 17278895 Clinical Trial.

7

[A case of multidrug-resistant non-small cell lung cancer responding to TS-1].

Imai H, Sunaga N, Kaira K, Ishihara S, Aoki H, Iijima H, Yanagitani N, Iwasaki Y, Tomizawa Y, Saito R, Mori M. Imai H, et al. Among authors: kaira k. Gan To Kagaku Ryoho. 2007 Feb;34(2):221-4. Gan To Kagaku Ryoho. 2007. PMID: 17301531 Japanese.

8

Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.

Kaira K, Ishizuka T, Yanagitani N, Sunaga N, Hisada T, Mori M. Kaira K, et al. Gan To Kagaku Ryoho. 2007 Feb;34(2):225-7. Gan To Kagaku Ryoho. 2007. PMID: 17301532

9

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer.

Kaira K, Sunaga N, Yanagitani N, Imai H, Utsugi M, Shimizu Y, Iijima H, Tomizawa Y, Hisada T, Ishizuka T, Saito R, Mori M. Kaira K, et al. Anticancer Drugs. 2007 Apr;18(4):471-6. doi: 10.1097/CAD.0b013e32801265eb. Anticancer Drugs. 2007. PMID: 17351400 Clinical Trial.

10

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy.

Sunaga N, Tomizawa Y, Yanagitani N, Iijima H, Kaira K, Shimizu K, Tanaka S, Suga T, Hisada T, Ishizuka T, Saito R, Dobashi K, Mori M. Sunaga N, et al. Among authors: kaira k. Lung Cancer. 2007 Jun;56(3):383-9. doi: 10.1016/j.lungcan.2007.01.025. Epub 2007 Mar 26. Lung Cancer. 2007. PMID: 17368623 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page